Leukemia, myeloid, accelerated-phase
MONDO:0021367The phase of chronic myeloid leukemia following the chronic phase (leukemia, myeloid, chronic-phase), where there are increased systemic symptoms, worsening cytopenias, and refractory leukocytosis.
Also known as: Accelerated Phase CML, Accelerated Phase Chronic Granulocytic Leukaemia, Accelerated Phase Chronic Granulocytic Leukemia, Accelerated Phase Chronic Myelocytic Leukaemia, Accelerated Phase Chronic Myelocytic Leukemia, Accelerated Phase Chronic Myelogenous Leukaemia, Accelerated Phase Chronic Myelogenous Leukemia, Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
3093 clinical trials for this condition and its sub-types, 30 tagged with Leukemia, myeloid, accelerated-phase itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New drug shows promise for aggressive leukemia but carries serious clot risk
Disease control Stopped earlyThis study tested the drug ponatinib in 51 adults with a fast-growing form of chronic myeloid leukemia (CML) who had little or no prior treatment. The goal was to see if ponatinib could control the disease by blocking a protein that drives leukemia growth. However, the drug can c…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Liver study for cancer drug stopped early – only 2 people joined
Knowledge-focused Stopped earlyThis study looked at how moderate or severe liver problems change the amount of the cancer drug oral azacitidine in the blood. It was designed for adults with certain blood cancers. The study was stopped early after only 2 people enrolled, so the results are very limited.
Phase 1 • Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC